+ more

Amman, 11 November 2014 - Hikma Pharmaceuticals, Jordan's leading pharmaceutical manufacturer, continued in its annual Breast Cancer campaigns to increase awareness of the disease, in partnership with the Jordan Breast Cancer Program (JBCP), where this year's campaign, an honorary celebration was organized for survivors at Wild Jordan Restaurant. The activity was dedicated to early detection, awareness of the disease as well personal stories of breast cancer survivors.

Ten cancer survivors shared their stories with Hikma employees and talked about how they can lead an active and healthy life. "Having breast cancer is not a limitation, in my case, it was an opportunity to discover the hidden potential in me to develop my life and explore new horizons that I wouldn't have thought before," explained one of the survivors.

Ms. Hana Darwazah Ramadan, Vice President of Corporate Communication at Hikma Pharmaceuticals, said, "One of Hikma Pharmaceuticals' corporate responsibility pillars is to positively influence and improve the livelihood of the society. Our health awareness campaigns complement our business objective of providing high quality medication and support our efforts towards a healthier society". 

Hikma has invested heavily in developing capabilities for the manufacturing of oncology products; these investments include the acquisition of Thymoorgan in Germany, a joint venture with Haosun in China and the recent establishment of the oncology production facility in the chemicals plant in Jordan.

distributed by